Scientist Anna Kostecka presented at a cross-institutional symposium on CAR T-cell assays. Her project uses cell-free DNA methylation profiling of liquid biopsies to monitor tumor and microenvironment responses to CAR T-cell immunotherapy in pediatric brain tumors.
